Circulatory osteoprotegerin is related to osteoporosis of the hip in patients with COPD

Present results suggest that osteoporosis of the hip is associated with increased circulatory levels of OPG in patients with COPD. OPG might serve as a biomarker of this COPD-related comorbidity.